Section 10. Investigational Medicinal Product Dossier (IMPD) and Common Technical Document (CTD)

Section 9. Non-clinical and clinical aspects concerning the regulation of advanced therapy medicinal product development

Section 11. Current implications and future perspectives in ATMP development

Section 12. Pharmaceutical quality system

Master´s Final Project.

Section 8. Quality, manufacturing and biosafety aspects in the regulation of advanced therapy medicinal product development

Section 7. Good Manufacturing Practice (GMP) as applied to ATMPS

Section 3. Cells with current and potential clinical application (25/03/25)

Section 2. Human Embryonic and Adult Cells and Tissues. Homeostasis, disregulation and disease

Section 4. Methods for manufacturing of cell based therapies

Section 5. Viral vectors and gene therapy

Section 6. Tissue engieneering for clinical application

Section 1. An introduction to Advanced Therapies Regulation: bench to bedside roadmap